Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Chemoradiotherapy Versus Chemoradiotherapy Alone in Muscle-invasive Bladder Cancer: The MK-3475-992/KEYNOTE-992 Trial
Gabrielle Tissot, Évanguelos Xylinas
Topics & Concepts
MedicinePembrolizumabBladder cancerCystectomyChemoradiotherapyChemotherapyRadiation therapyUrologyOncologyImmunotherapyPerioperativeInternal medicineCancerSurgeryBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and BiomarkersUrinary and Genital Oncology Studies